임상 검사 서비스 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트와 예측(2025-2034년)

Growth Factors of clinical laboratory services Market

The global clinical laboratory services market is projected to experience robust growth during the forecast period, driven by rising prevalence of chronic diseases, a growing geriatric population, and increasing awareness of clinical testing. Valued at USD 291.01 billion in 2025, the market is expected to reach USD 309.19 billion in 2026 and USD 545.79 billion by 2034, growing at a CAGR of 7.36% from 2026 to 2034. North America dominated the market in 2025, capturing 42.56% of the global share, due to high healthcare expenditure, advanced diagnostic infrastructure, and the integration of technologies like AI and Big Data for clinical testing.

Clinical laboratories play a crucial role in healthcare by conducting tests on clinical specimens to provide insights into patient health for diagnosis, treatment, and disease prevention. Beyond routine testing, these labs offer emergency response services, research support, and staff training. The rise in chronic disorders, including diabetes, cancer, and cardiovascular diseases, coupled with increasing geriatric populations, has significantly propelled the demand for laboratory-based diagnostics. For instance, the global population aged 80 years and above is projected to rise to 5% by 2050, creating a strong need for diagnostic services.

Key Market Drivers

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic disorders such as sickle cell disease, autoimmune diseases, cystic fibrosis, and various cancers has spurred the demand for clinical laboratory tests. The growing number of patient hospitalizations and prescriptions requiring diagnostic confirmation further fuels market expansion. For example, in the U.S., 129,624 genetic tests were conducted in 2022, reflecting an upward trend in laboratory utilization.

Increasing Healthcare Expenditure and Public-Private Partnerships: Governmental healthcare spending and public-private collaborations are enhancing access to diagnostic services. Countries like India have increased government health expenditure from 29% in 2014-2015 to 41.4% in 2019-2020, promoting accessibility to clinical testing.

Technological Advancements: Automation in clinical laboratories is a prominent trend, improving throughput, reducing manual errors, and enhancing the quality of results. For example, Flow Robotics' ScanID device launched in 2023 optimizes sample traceability while reducing pre-analytical errors. Key players are also introducing innovative diagnostic tests and automated lab solutions globally to meet rising demand.

Market Segmentation

By Test Type: The market is segmented into clinical chemistry, hematology, microbiology & cytology, genetic testing, and others. The clinical chemistry segment held the largest share in 2026 (32.78%), driven by the prevalence of diabetes, thyroid disorders, and widespread availability of at-home testing. Genetic testing is also growing due to increasing demand for early diagnosis of hereditary conditions.

By Age Group: The adult population dominated the market in 2026, holding 82.81% of the share, attributed to the higher prevalence of chronic diseases among geriatric patients. Pediatric testing continues to expand due to rising genetic disorders and favorable public health insurance policies for children.

By Source of Payment: The public segment led the market in 2026 (63.00%), supported by favorable government reimbursement policies. Private and out-of-pocket segments are growing due to higher disposable income and awareness regarding early diagnosis.

By Service Provider: Hospital-based laboratories dominated the market in 2026 (53.40%), driven by technological adoption, increased patient visits, and demand for advanced diagnostic services. Stand-alone and clinic-based labs are witnessing growth due to expansion strategies and new lab launches.

Regional Insights

North America remains the largest market, valued at USD 123.86 billion in 2025, supported by high healthcare expenditure and advanced diagnostics infrastructure. Europe holds a moderate share due to improved healthcare systems and government-backed insurance coverage. The Asia Pacific region is expected to witness the highest CAGR due to rising geriatric populations, increasing chronic diseases, and expansion of clinical laboratory networks. Latin America and the Middle East & Africa are gradually growing, fueled by healthcare infrastructure improvements and strategic collaborations by key players.

Competitive Landscape

The market is highly fragmented, with leading players including Laboratory Corporation of America, Quest Diagnostics, Illumina, Eurofins Scientific, and SRL Diagnostics. Companies are expanding their presence through acquisitions, partnerships, and the launch of advanced testing services. Notable developments include Laboratory Corporation of America opening a new anatomic pathology lab in Los Angeles (2022) and SRL Diagnostics acquiring Lifeline Laboratories in India (2023).

Conclusion

The global clinical laboratory services market is poised for substantial growth from 2025 to 2034, driven by increasing chronic diseases, rising geriatric populations, technological advancements, and favorable government initiatives. Hospital-based laboratories, clinical chemistry testing, and adult patient segments are expected to maintain dominance, while emerging regions, especially Asia Pacific, present significant growth opportunities. Continuous investments by key market players in automation, innovative diagnostics, and global expansion strategies will further strengthen the market's growth trajectory, enabling improved healthcare outcomes worldwide.

Segmentation By Test Type

• Clinical Chemistry
• Hematology
• Genetic Testing
• Microbiology & Cytology
• Others

By Age

• Pediatric
• Adult

By Source of Payment

• Public
• Private
• Out of Pocket

By Service Provider

• Hospital-based Laboratories
• Stand-alone Laboratories
• Clinic-based Laboratories
• Others

By Region

• North America (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country)
  • U.S.
  • Canada
• Europe (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
  • China
  • India
  • Japan
  • Australia
  • Southeast Asia
  • Rest of the Asia Pacific
• Latin America (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Test Type, By Age, By Source of Payment, By Service Provider, and By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Chronic Diseases, By Key Countries/Region, 2025
• 4.2. Key Industry Developments
• 4.3. Overview on Accreditation Bodies for Laboratories, By Key Countries
• 4.4. Impact of Covid-19 on the Market

5. Global Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Test Type
  • 5.1.1. Clinical Chemistry
  • 5.1.2. Hematology
  • 5.1.3. Genetic Testing
  • 5.1.4. Microbiology & Cytology
  • 5.1.5. Others
• 5.2. Market Analysis, Insights and Forecast - By Age
  • 5.2.1. Pediatric
  • 5.2.2. Adult
• 5.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 5.3.1. Public
  • 5.3.2. Private
  • 5.3.3. Out of Pocket
• 5.4. Market Analysis, Insights and Forecast - By Service Provider
  • 5.4.1. Hospital-based Laboratories
  • 5.4.2. Stand-alone Laboratories
  • 5.4.3. Clinic-based Laboratories
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Test Type
  • 6.1.1. Clinical Chemistry
  • 6.1.2. Hematology
  • 6.1.3. Genetic Testing
  • 6.1.4. Microbiology & Cytology
  • 6.1.5. Others
• 6.2. Market Analysis, Insights and Forecast - By Age
  • 6.2.1. Pediatric
  • 6.2.2. Adult
• 6.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 6.3.1. Public
  • 6.3.2. Private
  • 6.3.3. Out of Pocket
• 6.4. Market Analysis, Insights and Forecast - By Service Provider
  • 6.4.1. Hospital-based Laboratories
  • 6.4.2. Stand-alone Laboratories
  • 6.4.3. Clinic-based Laboratories
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Test Type
  • 7.1.1. Clinical Chemistry
  • 7.1.2. Hematology
  • 7.1.3. Genetic Testing
  • 7.1.4. Microbiology & Cytology
  • 7.1.5. Others
• 7.2. Market Analysis, Insights and Forecast - By Age
  • 7.2.1. Pediatric
  • 7.2.2. Adult
• 7.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 7.3.1. Public
  • 7.3.2. Private
  • 7.3.3. Out of Pocket
• 7.4. Market Analysis, Insights and Forecast - By Service Provider
  • 7.4.1. Hospital-based Laboratories
  • 7.4.2. Stand-alone Laboratories
  • 7.4.3. Clinic-based Laboratories
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Italy
  • 7.5.5. Spain
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Test Type
  • 8.1.1. Clinical Chemistry
  • 8.1.2. Hematology
  • 8.1.3. Genetic Testing
  • 8.1.4. Microbiology & Cytology
  • 8.1.5. Others
• 8.2. Market Analysis, Insights and Forecast - By Age
  • 8.2.1. Pediatric
  • 8.2.2. Adult
• 8.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 8.3.1. Public
  • 8.3.2. Private
  • 8.3.3. Out of Pocket
• 8.4. Market Analysis, Insights and Forecast - By Service Provider
  • 8.4.1. Hospital-based Laboratories
  • 8.4.2. Stand-alone Laboratories
  • 8.4.3. Clinic-based Laboratories
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Test Type
  • 9.1.1. Clinical Chemistry
  • 9.1.2. Hematology
  • 9.1.3. Genetic Testing
  • 9.1.4. Microbiology & Cytology
  • 9.1.5. Others
• 9.2. Market Analysis, Insights and Forecast - By Age
  • 9.2.1. Pediatric
  • 9.2.2. Adult
• 9.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 9.3.1. Public
  • 9.3.2. Private
  • 9.3.3. Out of Pocket
• 9.4. Market Analysis, Insights and Forecast - By Service Provider
  • 9.4.1. Hospital-based Laboratories
  • 9.4.2. Stand-alone Laboratories
  • 9.4.3. Clinic-based Laboratories
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Clinical Laboratory Services Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Test Type
  • 10.1.1. Clinical Chemistry
  • 10.1.2. Hematology
  • 10.1.3. Genetic Testing
  • 10.1.4. Microbiology & Cytology
  • 10.1.5. Others
• 10.2. Market Analysis, Insights and Forecast - By Age
  • 10.2.1. Pediatric
  • 10.2.2. Adult
• 10.3. Market Analysis, Insights and Forecast - By Source of Payment
  • 10.3.1. Public
  • 10.3.2. Private
  • 10.3.3. Out of Pocket
• 10.4. Market Analysis, Insights and Forecast - By Service Provider
  • 10.4.1. Hospital-based Laboratories
  • 10.4.2. Stand-alone Laboratories
  • 10.4.3. Clinic-based Laboratories
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Laboratory Corporation of America
    • 11.2.1.1. Overview
    • 11.2.1.2. Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Strategies
    • 11.2.1.5. financials (Based on Availability)
  • 11.2.2. Quest Diagnostics Incorporated
    • 11.2.2.1. Overview
    • 11.2.2.2. Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Strategies
    • 11.2.2.5. financials (Based on Availability)
  • 11.2.3. Illumina, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Strategies
    • 11.2.3.5. financials (Based on Availability)
  • 11.2.4. Eurofins Scientific
    • 11.2.4.1. Overview
    • 11.2.4.2. Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Strategies
    • 11.2.4.5. financials (Based on Availability)
  • 11.2.5. DDRC SRL Diagnostics (SRL Diagnostics)
    • 11.2.5.1. Overview
    • 11.2.5.2. Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Strategies
    • 11.2.5.5. financials (Based on Availability)
  • 11.2.6. UNILABS (A.P. Moller Holding A/S)
    • 11.2.6.1. Overview
    • 11.2.6.2. Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Strategies
    • 11.2.6.5. financials (Based on Availability)
  • 11.2.7. NeoGenomics Laboratories, Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Strategies
    • 11.2.7.5. financials (Based on Availability)
  • 11.2.8. ARUP Laboratories
    • 11.2.8.1. Overview
    • 11.2.8.2. Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Strategies
    • 11.2.8.5. financials (Based on Availability)
  • 11.2.9. Sonic Healthcare Limited
    • 11.2.9.1. Overview
    • 11.2.9.2. Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Strategies
    • 11.2.9.5. financials (Based on Availability)